Mallinckrodt to Acquire Therakos for $1.325B

News   Aug 11, 2015

 
Mallinckrodt to Acquire Therakos for $1.325B
 
 
 

RELATED ARTICLES

Lab Innovations returns to the NEC, Bimingham , UK

News

Save the date for the UK’s only lab-dedicated exhibition showcase!

READ MORE

Immune Cells Hold Promise In Slowing ALS

News

Recent research showed that a new immunotherapy was safe for patients with ALS and also revealed surprising results that could bring hope to patients who have this relentlessly progressive and fatal disease.

READ MORE

Researchers Awarded $28M for Illuminating Druggable Genome NIH Grants

News

Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE